Alberto J. Montero

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura et al. · Cancer Immunology Immunotherapy · 2008 · 1.2K citations

Clinical Cancer Stage, Tumor Biology, Medicine +10

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

François‐Clément Bidard, Virginia Kaklamani, Patrick Neven et al. · Journal of Clinical Oncology · 2022 · 626 citations · Full text

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells

Samantha Solito, Erika Falisi, C. Marcela Díaz‐Montero et al. · Blood · 2011 · 329 citations · Full text

Treating Breast Cancer in the 21st Century: Emerging Biological Therapies

Gabriel Tinoco, Sean Warsch, Stefan Glück et al. · Journal of Cancer · 2013 · 172 citations · Full text

Tumor Biology, Medical Treatment, Oncology +15

Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial

Vakaramoko Diaby, Georges Adunlin, Alberto J. Montero · PharmacoEconomics · 2013 · 141 citations

Prognostic Evaluation, Health Policy, Health Economics +11